28-Oct-2024
The surge in the geriatric population and the high population suffering from diabetes are some of the key driving factors of the market.
The Continuous Glucose Monitoring Systems Market is expected to grow at a CAGR of 20.6% from 2020-2030, according to a new research report by Next Move Strategy Consulting.
Continuous glucose monitoring system is a device that measures the glucose levels present in blood in real time or continuously. CGM devices provides an easy and effective way to control diabetes. Rise in incidences of diabetes worldwide, rising awareness in developing and underdeveloped economies, various advantages of CGMS devices over POC glucometers and underdeveloped economies, and technological advancements with major focus on developing CGMS devices majorly drive the continuous glucose monitoring systems market growth. However, lack of adequate reimbursement for such devices is acting as the key barrier to the wide scale adoption of these devices.
The global Continuous Glucose Monitoring Systems market share has been analysed based on component, demographics, end user, and region. Based on component, the market is segmented into transmitters & receivers and integrated insulin pumps; and sensors. On the basis of demographics, CGMS are categorized into child population (≤14 years) and adult population (>14 years). Based on end user, the market is classified into clinics and diagnostics centers, ICUs, and home healthcare. Geographic breakdown and analysis of each of the previously mentioned segments include regions comprising North America, Europe, Asia-Pacific, and RoW.
Geographically, North America dominates the continuous glucose monitoring systems market, accounting for the highest share and is anticipated to maintain this trend throughout the forecast period. This is attributed to factors such as the rising prevalence of diabetes among people and various government initiatives about the reimbursement scenarios for such devices.
Browse key industry insights from the report, Continuous Glucose Monitoring Systems Market by Components (Sensors, Transmitters & Receivers, and Integrated Insulin Pumps), Demographics (Child Population (<=14years), and Adult Population (>14years), and End User (Clinics and Diagnostics Centers, ICUs, and Home Healthcare) - Global Opportunity Analysis and Industry Forecast, 2020-2030
According to the report, some of the key players in the market are Abbott Laboratories, Dexcom, Inc., A. Menarini Diagnostics, Echo Therapeutics, Inc., GlySens Incorporated, Johnson & Johnson, Medtronic plc, Senseonics Holdings, Inc., and F. Hoffmann-La Roche Ltd. and many more.
Key Insights from the Continuous Glucose Monitoring Systems Market Report:
The CGMS market report is segmented by components, demographics, adult population, end user, and geography.
Get a free sample on the Continuous Glucose Monitoring Systems Market report
About Next Move Strategy Consulting
Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.
We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision-making for businesses.
For more insights, browse reports
The increased prevalence of non-communicable diseases is dri...
The increased geriatric population rates are driving the Tai...
Increasing healthcare investment is driving the Uruguay in-v...
This website uses cookies to ensure you get the best experience on our website. Learn more
✖